Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01747083
Recruitment Status : Completed
First Posted : December 11, 2012
Last Update Posted : October 24, 2013
Information provided by (Responsible Party):
LG Life Sciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2013
  Actual Study Completion Date : April 2013